Author

Bala Başak Öven

Observed names: Bala Basak Oven, Oven, Bala Basak

Institutions: Yeditepe University, Yeditepe University Hospital

Observed institutions: Yeditepe University, Yeditepe University Hospital

ORCID: 0000-0002-9921-4089

Observed ORCID: 0000-0002-9921-4089

OpenAlex ID: A5122059859

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

2026 · İlker Nihat Ökten, Tuba Baydaş, et al. · Journal of Clinical Medicine · 1

The role of 68Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited 18F-FDG Uptake

2026 · Gamze Beydağı, Nalan Alan Selçuk, et al. · Molecular Imaging and Radionuclide Therapy

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

2026 · Bahadır Köylü, Özde Melisa Celayir, et al. · Cancers

Real-world outcomes of first-line treatments in patients with metastatic non-small cell lung cancer: Final analysis of the Registurk-Lung registry.

2026 · Sema Sezgin Goksu, Mehmet Artac, et al. · Journal of Clinical Oncology

Systemic Anticancer Therapy Near the End of Life: Association of Treatment Escalation With Hospital-Centered Care in Metastatic Cancer: A Retrospective Cohort Study

2026 · Ezgi Çoban, Murat Sarı, et al. · American Journal of Hospice and Palliative Medicine®

Abstract CT176: ctDNA as a prognostic and pharmacodynamic biomarker following first- or later-line treatment of advanced NSCLC with BNT116 + cemiplimab

2026 · Janet L. Markman, Chiara Dalle Fratte, et al. · Cancer Research

Are the results of clinical trials in patients with NSCLC reflected in real life? The Registurk-Lung study

2024 · Dane, Faysal, Harputluoglu, Hakan, et al. · Bursa Uludag University - AVESIS

Works count: 7

Citation count: 1

H-index: 1

I10-index: